在乳腺癌中使用Trop2向治疗
Yixuan Hu1, Yinxing Zhu1,2, Dan Qi3
1Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Biomarker research
|August 12, 2024
概括
人类热囊细胞表面抗原2 (Trop2) 是一个有前途的癌症标,特别是三阴性乳腺癌 (TNBC). 针对Trop2的疗法,包括抗体药物合物,如Sacituzumab govitecan,显示出显著的临床有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 人类热囊细胞表面抗原2 (Trop2) 是一种细胞表面糖蛋白,在包括乳腺癌在内的各种癌症中过度表达.
- 在瘤扩散,入侵和转移中Trop2的作用使其成为一个重要的治疗点.
- 高Trop2表达在三阴性乳腺癌 (TNBC) 和其他亚型中强调了其临床相关性.
研究的目的:
- 审查Trop2的结构和功能.
- 讨论主要的Trop2向抗体-药物联合体 (ADC) 和新型药物.
- 提供临床试验和Trop2向癌症治疗的未来方向的概述.
主要方法:
- 关于Trop2在癌症中的结构,功能和表达的文献综述.
- 对 Trop2 向疗法的临床试验数据的分析.
- 综合有关已批准和正在研究的Trop2向药物的信息.
主要成果:
- 在乳腺癌亚型,特别是TNBC中,Trop2是经过验证的目标.
- 针对Trop2的ADCs,如Sacituzumab govitecan,已经在转移性乳腺癌中表现出有效性.
- 几种新的Trop2向药物正在调查中,显示未来治疗的前景.
结论:
- 针对Trop2的治疗代表了乳腺癌治疗的重大进步,特别是TNBC的治疗.
- 针对Trop2的ADC和其他药物的开发为治疗选择有限的患者提供了新的希望.
- 持续的研究和临床试验对于优化Trop2向策略和扩大其应用至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K